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Abstract
Objective—To describe characteristics of cervicovaginal cytokines obtained during pregnancy 
from women who subsequently delivered at term.
Study Design—We used repeated measures of 20 cervicovaginal cytokines, collected on average 
on a monthly basis, from the second to the ninth month of gestation among 181 term pregnancies 
in the Mexico City Pregnancy Research on Inflammation, Nutrition, & City Environment: 
Systematic Analyses cohort (2009–2014). Cytokines were quantified using multiplex assay.
Results—Cytokine distributions differed more between than within cytokines. Across trimesters, 
cytokines interleukin (IL)-1Ra, IL-1α, and IL-8 consistently had high concentrations compared 
with other measured cytokines. Cytokine intraclass correlation coefficients ranged from 0.41 to 
0.82. Spearman’s correlation coefficients among cytokine pairs varied but correlation directions 
were stable; 95.3% of the 190 correlation pairs remained either negative or positive across 
trimesters. Mean longitudinal patterns of log-transformed cytokines from Tobit regression varied 
across but less within cytokines.
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Conclusion—Although mean concentrations of cervicovaginal cytokines among term 
pregnancies were high, they were largely stable over time. The high cytokine concentrations 
corroborate that pregnancy is associated with an active inflammatory state. These characterizations 
may serve as a baseline for comparison to other obstetric outcomes, which may be helpful in 
understanding deviations from normal gestational inflammation.
Keywords
appropriate statistical methods; cytokines; inflammation; patterns; longitudinal data; pregnancy; 
PRINCESA cohort; Tobit regression; term birth
Inflammation is a normal part of human pregnancy; it is particularly needed for 
physiological events such as implantation and parturition.1 Interestingly, parturition is 
associated with inflammatory states similar to those found in pathological conditions such as 
infection,2 and this inflammation may occur in the absence of microorganisms (identified 
using culture and molecular methods) in the amniotic cavity, a condition known as sterile 
inflammation.3 Additionally, other points in normal pregnancy are marked by controlled 
systemic inflammation.4,5 However, inadequately regulated inflammation can lead to 
pathological states, including adverse pregnancy outcomes.6 To date, there is limited 
characterization of the range of normal variation in inflammation biomarkers such as 
cytokines during a “healthy” pregnancy and inflammatory characteristics that constitute a 
pathologic departure from the norm have not been clearly elucidated.
The role of proinflammatory and anti-inflammatory cytokines in pregnancy—especially 
their potential influence on the length of pregnancy—is being increasingly evaluated. 
However, the dearth of longitudinal studies describing cervicovaginal cytokine patterns over 
the course of pregnancy7 highlights the need for comprehensive studies describing the range 
of “normal” immunologic responses to pregnancy.
To fill these gaps, our objective was to characterize trajectories and concentrations of 20 
cervicovaginal cytokines during pregnancy among women who delivered at term. We 
selected the cervicovaginal compartment as an acceptable proxy of intrauterine milieu 
conditions during pregnancy. Cytokines were selected from among those previously 
evaluated in pregnant women8 to represent four important categories of cytokines, namely: 
proinflamma-tory, anti-inflammatory, chemokines, and growth factor.
Methods
This study uses data collected from pregnant women in Mexico City participating in the 
Pregnancy Research on Inflammation, Nutrition, & City Environment: Systematic Analyses 
(PRINCESA) cohort.9 The study was approved by the Institutional Review Board from the 
University of Michigan and ethics committees from the Mexico City Health Ministry 
(Secretaría de Salud del Gobierno dela Ciudad de México), and the School of Medicine of 
the National Autonomous University of Mexico (Facultad de Medicina, Universidad 
Nacional Autonoma de México [UNAM]).
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Pregnant women were enrolled in the study during either their first or second trimester of 
pregnancy. Samples were obtained at enrollment and approximately monthly thereafter. 
Participants 18 years or older who lived and/or worked in metropolitan Mexico City (Mexico 
City and surrounding areas), and provided written informed consent, were enrolled in the 
study between 2009 and 2014. All participants agreed to attend monthly prenatal visits and 
all had singleton pregnancies. Clinical samples (blood, urine, cervicovaginal exudates) and 
demographic information were collected during monthly visits. Additionally, participants 
were eligible if they did not present with any medical or obstetric complications; those who 
subsequently developed complications were referred to another hospital for appropriate 
prenatal care.
Gestational age was calculated using infant’s birth date and the first day of last menstrual 
period based on trustworthy (98.9% of participants) and exact (99.4% of participants) recall 
from the earliest available visit record or screening. Trustworthy and exact recall were 
assessed by asking participants, “Is your last menstrual period date a trustworthy recall?” 
and “Is your last menstrual period date an exact recall?” respectively. These analyses were 
limited to the 181 participants who delivered at term and for whom data fromat least one 
visit(first or follow-up visit) were available at the time of data analysis.
We quantified cytokines from cervicovaginal samples collected at each monthly visit; 
samples were stored at −80°C until processing. Study participants were enrolled during their 
first or second trimester of pregnancy; samples were obtained at enrollment and 
approximately monthly thereafter. Therefore, initial samples were from the first trimester for 
some participants and second trimester from other participants. All samples obtained prior to 
when each participant was in labor were tested for cytokines. Samples were collected using 
a Dacron swab that was rotated for 10 seconds in the cervicovaginal section of the 
reproductive tract, the tip submerged, and washed repeatedly in a solution of phosphate 
buffered saline added with a cocktail of protease inhibitors (Sigma). Infection status was 
evaluated based on identification of microorganisms by culture count and clinical 
characteristics during genital and pelvic examinations. We assigned points according to 
these characteristics and classified patients as infected or noninfected using a cutoff in the 
sum of points. Lactobacillus spp. abundance was categorized as absent (three points), scarce 
(two points), intermediate (one point), and abundant (zero point). Other microorganism 
abundance was classified as absent (zero point), scarce (one point), intermediate (two 
points), and abundant (three points). Patients with three points or less were classified as 
noninfected; patients with four or more points were classified as infected. The opposite 
classification between Lactobacillus spp. and other microorganisms reflects different effects 
that these two groups of organisms have on lower reproductive health.10,11 Identified 
microorganisms included Streptococcus spp., Staphylococcus spp., Haemophilus spp., 
Gardnerella vaginalis, Escherichia coli, Staphylococcus aureus, Bifidobacterium spp., 
Proteus spp., Bacillus spp., Streptococcus agalactiae, Candida albicans, and Neisseria 
gonorrhoeae.
Clinical cervical vaginal infection was based on the presence of abnormal vaginal discharge 
and reported itching, burning, or malodor (one point). Isolated symptoms and normal 
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discharge were assigned zero point. A summary score which incorporated both microbiology 
and symptom scores was used to determine final infection status.
A total of 20 cytokines were quantified in monthly cervicovaginal samples using the MAP 
human cytokine/chemokine magnetic bead panel kit (Millipore Corporation, Billerica, MA).
12
 Cytokines quantified were: eotaxin, interferon gamma (IFN-γ), IL-10, IL-12p40, 
IL-12p70, IL-17, IL-1Ra, soluble IL-2 receptor α (sIL-2Rα), IL-1α, IL-1β, IL-2, IL-4, 
IL-6, IL-8, IFN-γ-inducible protein (IP-10), monocyte chemoattractant protein-1 (MCP-1), 
macrophage inflammatory protein-1 α (MIP-1α), macrophage inflammatory protein-1 β 
(MIP-1β), tumor necrosis factor α (TNF-α), and vascular endothelial growth factor 
(VEGF).
Analyses were done in the laboratories of UNAM or its affiliate, the National Institute of 
Genomic Medicine, using previously frozen samples following the published protocol of the 
manufacturer.12 Analyses were done in duplicate for every sample, and standard controls 
were run.
First-time thawed samples were briefly vortexed and centrifuged for 20 to 30 seconds, and 
25 μL of thawed cervicovaginal exudate samples were added to each well. Twenty-five μL of 
previously mixed beads were added to each well and 200 μL of wash buffer was added to all 
wells before the addition of 25 μL of detection antibodies to each well. Twenty-five μL 
streptavidin–phycoerythrin were subsequently added to the wells, washed twice, and then 
run on MAGPIX with XPONENT software for analysis.
Per the manufacturer’s protocol, the minimum detectable concentration in pg/mL, intra-
assay coefficient of variation (CV) %, and interassay CV %, respectively for each cytokine 
are shown in Supplementary Appendix 1 (available in the online version). Observations 
below the limit of detection (LOD) were transformed as LOD/√2 for analysis. In addition, 
some samples had cytokine concentrations that exceeded the upper LOD of the equipment 
and were quantified as more than 10,000 pg/mL. For statistical analyses, these right 
censored observations were transformed by adding 10 pg/mL.
Statistical analyses were performed using SAS Statistical Software version 9.3 (SAS 
Institute Inc. Cary, NC) and R version 3.2.2 (R Foundation for Statistical Computing, 
Vienna, Austria). Descriptive statistics on demographic and obstetric/gynecologic 
characteristics were generated. Probability of infection for each trimester was determined by 
calculating the mean across all participants for the number of infections per trimester per 
participant/number of visits per trimester per participant. The distribution of each cytokine 
was examined using histograms and q–q plots. We compared ranks (Kruskal–Wallis’ test) 
for each of the 20 cytokines by body mass index (BMI) categories using (1) the four 
standard BMI categories and (2) a second two-group classification format which grouped 
underweight and normal in one category and overweight and obese in another category.
We calculated select percentiles of each cytokine by trimester. In addition to having 
censored observations, cytokine concentrations were not normally distributed. Therefore, we 
used empirical cumulative distribution functions (ECDFs) to graphically represent the 
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distributions for each cytokine by select months of gestation. The cenfit function from the 
NADA package in R was used to generate ECDF plots.13
Spearman’s correlations were calculated for pairs of cytokines for each trimester, using the 
LOD/√2 substitution for values below the LOD, and the upper LOD plus 10pg/mL(10,010 
pg/mL) substitution for values above the upper LOD. Correlations were graphically 
illustrated using heat maps.14 We utilized only one observation per woman for each trimester 
to eliminate the influence of correlation due to repeated measurements, so Spearman’s 
correlation coefficients were computed using cytokine concentrations from the gestation 
month with the highest number of observations for each trimester. To enhance 
interpretability of the heat maps, the ordering of cytokines on the axes was based on 
functional groups. The p-values that assessed the statistical significance of pairwise 
correlations were adjusted to control the false discovery rate.15
We also calculated intraclass correlation coefficients (ICCs) for each cytokine. Conventional 
methods used to calculate ICCs were not appropriate due to censored observations and a 
lack of normality even after log transformation. To address lack of normality which is 
important for ICC calculations based on censored data, we applied the Box–Cox 
transformation16 to the cytokine with the lowest percent of observations below the LOD, and 
identified that an inverse fourth root transformation yielded distributions closer to the normal 
distribution; this transformation was deemed appropriate and applied to all cytokines. To 
account for the inverse fourth root transformation, we adapted a SAS NLMIXED model for 
repeated measures, which uses log-normally distributed data, to estimate ICCs17; this 
procedure uses maximum likelihood estimation to fit mixed effects models and accounts for 
left censoring of log-normally distributed data.
Finally, we characterized average cytokine patterns over time in women who delivered at 
term using Tobit regression (Survival package in R).18 Tobit regression is a parametric 
regression which properly accounts for both left and right censoring19 and may be used for 
data with repeated measures.20 Participants were clustered by identification number and the 
models included a set of variables representing a natural cubic spline parameterization of 
gestational weeks at the time of the ith observation in the jth woman. A working 
independence assumption was used to fit the model, and robust standard errors of model 
coefficients were computed. We used the estimated parameters to construct plots that 
illustrate mean cytokine patterns during the course of pregnancy. We also considered the 
sensitivity of results to not adjusting for infection status.
Results
Cytokines were quantified from samples obtained from the end of second month to the end 
of pregnancy among 181 women who were not actively in labor. The median gestational age 
at enrollment was 12.4 weeks (range 7–25.4 weeks) and the median number of visits over 
the course of pregnancy was four visits (range 1–8 visits). Supplementary Appendix 2 
(available in the online version) shows a distribution of visits by gestational month. Women 
were primarily in the 20 to 35 age group (70%) and more than half (54.7%) had at least one 
previous child. Most participants were either normal weight (33.2%) or overweight (32.6%) 
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prior to pregnancy. Mean ranks from Kruskal–Wallis’ tests were not different across BMI 
categories for the 20 cytokines evaluated (data not shown). The probability of reproductive 
tract infection was highest in the second trimester (0.37) and decreased in the third trimester 
(0.28) (Table 1).
The percentage of observations below the lower LOD and above the upper LOD for each 
cytokine varied across pregnancy with no consistent pattern in the monthly percentages (data 
not shown). Most cytokines had 10 to 30% of values below the lower LOD; exceptions were 
IP-10, MCP-1, MIP-1β, and IL-8 with less than 5%, and IL-4 and IL-12p40 with more than 
40% below the lower LOD. For the majority of cytokines, less than 5% of the values were 
above the upper LOD, including five cytokines (IL-2, TNF-α, IL-12p70, IL-17, and IFN-γ) 
with no observations above the upper LOD (Supplementary Appendix 3, available in the 
online version). Cytokine concentrations were not normally distributed, so log-transformed 
values or inverse-fourth-root–transformed values were used in analyses that required a 
normal distribution and indicated when this was the case; all other analyses used 
nontransformed cytokine values.
The distributions of cytokine values in their natural scale differed across cytokines and 
across trimesters (Table 2). Three cytokines (one anti-inflammatory [IL-1Ra] and two 
proinflammatory [IL-1α, and IL-8]) consistently had high concentrations across trimesters 
and compared with other cytokines for the study-specific median, 75th, and 95th percentiles, 
while IP-10 and VEGF consistently had high concentrations at the 95th percentile across 
pregnancy but substantially lower concentrations at the 50th and 75th percentiles compared 
with IL-1Ra, IL-1α and IL-8. Similarly, plots for all 20 cytokines for the selected gestational 
months (months 3, 5, and 7, Supplementary Appendix 4, available in the online version), 
showed differences in ECDFs across cytokines, but ECDFs did not differ across time for 
most cytokines.
Many of the cytokines exhibited good reproducibility (defined as ICCs between 0.60 and 
0.74)21 over the course of pregnancy (Table 3). Across all cytokines, ICCs ranged from 0.41 
to 0.82 (which included the following three reproducibility categories [ranges], namely: fair 
[0.40–0.59], good [0.60–0.74], and excellent [≥ 0.75]).21 Correlation heat maps for month 3 
(Fig. 1), and months 5 and 7 (Supplementary Appendix 5, available in the online version) 
and the 570 Spearman’s correlation coefficients (Supplementary Appendix 6, available in 
the online version) among all possible pairs of the 20 cytokines illustrate that the magnitude 
of correlation coefficients varied over time, but the direction of correlation was stable over 
the course of pregnancy; 95.3% of the 190 correlation pairs remained either negative or 
positive at the three points evaluated in pregnancy.
The mean longitudinal patterns of log-transformed cytokines adjusted for lower reproductive 
tract infection status varied across cytokines, but little variability was observed within 
cytokines (Fig. 2, Supplementary Appendix 7, available in the online version). Mean levels 
of IL-1Ra, IL-1α, and IL-8 were high throughout pregnancy compared with other cytokines 
evaluated. IL-1Ra, IL-1α, and IL-8 were among the few cytokines that exhibited subtle 
changes over time; specifically, IL-1Ra and IL-1α exhibited a pattern of slight decrease 
toward the end of the first trimester of pregnancy followed by a slight increase late in the 
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second trimester (around week 25) and a decrease by the end of pregnancy. IL-8 had a gently 
decreasing trend beginning at the 30th week of gestation. Lower reproductive tract infection 
did not appear to substantially influence mean cytokine patterns, as unadjusted patterns (data 
not shown) did not differ from patterns adjusted for infection (shown in Fig. 1 and 
Supplementary Appendix 7, available in the online version).
Discussion
We used longitudinal data to describe characteristics of individual and pairs of 20 
cervicovaginal cytokines among 181 women in the PRINCESA cohort who delivered at term 
without major obstetrical and medical complications. Our results suggest that “normal” 
immunologic state of pregnancy encompasses a range of inflammation levels that are not 
necessarily indicative of pathology.
Infection is a known stimulant of immune activity, so the finding that mean cervicovaginal 
patterns were unaffected by infection was unexpected. However, previous studies have had 
inconsistent results (reviewed in Mitchell and Marrazzo22). Perhaps because pregnancy 
encompasses periods of varying severity of inflammation including concentrations that may 
be reflective of pathology,1 infection did not further influence inflammation levels in this 
population. It is also possible that in the context of a strict monthly prenatal follow-up of 
women and treatment of infections, participants did not reach an advanced stage of 
inflammation.
Additionally, cytokines in this study exhibited fair to excellent reproducibility, suggesting 
that, on average, cytokines are stable over time among women who will deliver at term. 
Notably, four of the six cytokines with ICCs indicating fair reproducibility were chemokines 
IL-8, IP-10, MCP-1, and MIP-1α (the two exceptions were IL-6 and VEGF). A fair 
category indicates that these cytokines exhibited some degree of variability within 
participants across the study sample and may be reflective of frequent expression of 
chemokines for their many different roles, which include placental development, immune 
efficiency and tolerance, and cellular differentiation.23 Although stability in mean cytokine 
levels was corroborated by a summary within-participant measure for most cytokines, fair 
reproducibility seen particularly in chemokines suggests that, possibly due to their 
physiologic roles, caution and further investigation may be needed when evaluating 
chemokines.
In one of few longitudinal studies identified, Donders et al evaluated—among 92 women in 
Leuven, Belgium—whether six vaginal cytokines (IL-6, IL-8, IL-1β, IL-1Ra, leukemia 
inhibitory factor, and TNF-α) varied during the course of uncomplicated pregnancy (n = 30) 
and further compared trimester-specific cytokine distributions to nonpregnant participants (n 
= 62).24 Cytokine concentration ranges were different in that study compared with ours, so 
comparison between the two studies focuses on patterns. Similar to our results, Donders et al 
reported a slight decrease in mean concentration of IL-1β between the first and second 
trimesters followed by a slight increase during the third trimester. IL-6 levels were low with 
an increase at the end of pregnancy in both studies, but Donders et al showed a steeper 
increase. Although greatly different numerically in terms of concentrations, patterns were 
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similar for IL-8 until the very end of pregnancy where we saw a decrease not seen in 
Donders et al. This may reflect true differences between the studies or might be influenced 
by the availability of data up to 40 weeks in our study, whereas Donders et al collected data 
up to 38 weeks of gestation. Finally, mean levels of TNF-α were low, and IL-1Ra showed 
variability over time in both studies, but IL-1Ra patterns were different.
Higher expression of IL-10 and its receptor compared with proinflammatory cytokines in 
placental tissues has been reported,25 but patterns similar to our findings have also been 
reported for cervical and cervicovaginal IL-10 cytokines. Kutteh and Franklin, in a study 
that evaluated the levels of cervical cytokines and immunoglobulins among 36 pregnant 
women with no known health problems, did not detect measurable levels of IL-10 in any of 
the three trimesters evaluated. However, among the same participants, mean levels of 
proinflammatory cytokine IL-1β were 4,261, 12,899, and 11,620 pg/mL during the first, 
second, and third trimesters, respectively. IL-6 was considerably lower(average 323 pg/mL) 
in the first and the second trimesters.26 In another study of 63 asymptomatic women at risk 
for spontaneous preterm birth (due to a history of preterm birth risk factors), Amabebe et al 
reported similar patterns of low cervicovaginal IL-10 and higher proinflammatory cytokines 
among 25 and 33 term births at weeks 20 to 22 and 26 to 28 of gestation, respectively.27 It is 
unclear why these differences exist between studies and may need to be investigated in 
appropriately designed future studies.
Information on correlations among cervicovaginal cytokines in term births is limited in 
published work; the few studies identified primarily focused on correlations between 
cytokines, at select points28 and in the context of other factors.29–31 Therefore, the current 
study fills a specific gap about the relationship between pairs of cervicovaginal cytokines 
during pregnancy.
The strengths of this study include: the use of appropriate statistical methods for censored 
data, and evaluation of pairwise correlations at multiple points in gestation; but future 
studies that utilize additional analytic approaches may help untangle the complexities of the 
inflammatory process.
One limitation is that the percentage of observations below the lower LOD was high—
although comparable to other studies.8,32 Another limitation is that only two participants had 
cytokine data for the second month of gestation, so our results represent a characterization of 
cytokines from the third month to the end of pregnancy prior to the start of labor and may 
not have captured potential variability of cytokines during implantation and labor. The 
inability to use the same set of participants over the course of pregnancy is a limitation of 
this study. In addition, the role of specific lower reproductive tract infections, such as 
bacterial vaginosis, on mean cytokine concentrations was not evaluated in this study. The use 
of LMP to estimate gestational age is another limitation to consider. Finally, the method 
used to diagnose lower reproductive tract infection has not been validated and may represent 
a limitation.
In conclusion, our findings highlight important characteristics of cervicovaginal cytokines 
during term pregnancy, and suggest that cytokine stability during pregnancy may be a useful 
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characteristic to evaluate for potential differences between term and other obstetric 
outcomes. Additionally, the finding of very high cytokine levels in term pregnancies further 
corroborates that pregnancy—independent of pathology/infection—is associated with an 
inflammatory state. These results may serve as a baseline against which future studies 
involving other pregnancy outcomes may be compared.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Heat map of Spearman’s correlation coefficients for cervicovaginal cytokines at month 3 of 
gestation. Darker colors indicate stronger negative (tan) or positive (blue) correlations. The 
c-prefix denotes cervicovaginal cytokine.
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Fig. 2. 
Infection adjusted patterns of IL-1Ra, IL-4, IL-10, and IL-12p40 (Tobit regression models). 
Y-axis denotes log-transformed cytokine concentrations (in pg/mL) and the X-axis indicates 
gestational weeks. IL, interleukin.
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Table 1
Demographic and obstetric characteristics of Mexican women in the PRINCESA cohort delivering term births, 
2009 to 2014 (N = 181)
Age N (%)
 < 20 34 (18.8)
 20–35 127 (70.2)
 > 35 20 (11.1)
Pre-pregnancy BMI N (%)
 < 18.5 kg/m2 9 (5.0)
 18.5–24.9 kg/m2 60 (33.2)
 25–29.9 kg/m2 59 (32. 6)
 ≥ 30 kg/m2 31 (17.1)
 Missing 22 (12.2)
Parity N (%)
 Nulliparous 51 (28.2)
 Parous 99 (54.7)
 Missing 31 (17.1)
Reproductive tract infection Probability of infectiona
 Trimester 1 0.31
 Trimester 2 0.37
 Trimester 3 0.28
Abbreviations: BMI, body mass index; PRINCESA, Pregnancy Research on Inflammation, Nutrition, & City Environment: Systematic Analyses.
a
Mean of (number of infection per trimester/number of visits for each participant per trimester).
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Table 3
Intraclass correlation coefficients of cervicovaginal cytokine concentrations in term births (N = 181), 
PRINCESA cohort, 2009 to 2014
Cytokine Inverse fourth root
Anti-inflammatory
 IL-1Ra 0.67
 IL-4 0.75
 IL-10 0.64
 sIL-2Rα 0.71
 IL-12p40 0.79
Proinflammatory
 IL-1α 0.68
 IL-1β 0.64
 IL-2 0.62
 IL-6 0.50
 IL-8 0.41
 TNF-α 0.62
 IL-12p70 0.79
 IL-17 0.65
 IP-10 0.50
 IFN-γ 0.78
 MCP-1 0.45
 MIP-1α 0.56
 MIP-1β 0.58
 Eotaxin 0.82
 VEGF 0.45
Abbreviations: IFN-γ, interferon gamma; IL, interleukin; IP-10, IFN-γ-inducible protein; MCP-1, monocyte chemoattractant protein-1; MIP-1α, 
macrophage inflammatory protein-1 α; MIP-1β, macrophage inflammatory protein-1 β; PRINCESA, Pregnancy Research on Inflammation, 
Nutrition, & City Environment: Systematic Analyses; sIL-2Rα, soluble IL-2 receptor α; TNF-α, tumor necrosis factor α; VEGF, vascular 
endothelial growth factor.
Am J Perinatol. Author manuscript; available in PMC 2020 October 12.
